JAMA Internal Medicine: Parkinson Disease/Parkinsonian Disorders Topic Collection http://archinte.jamanetwork.com/ en-us Mon, 22 Apr 2013 00:00:00 GMT Mon, 22 Apr 2013 21:46:04 GMT Silverchair editor@archinte.jamanetwork.com webmaster@archinte.jamanetwork.com Trends in On-label and Off-label Modafinil Use in a Nationally Representative Sample http://archinte.jamanetwork.com/article.aspx?articleID=1669100 Mon, 22 Apr 2013 00:00:00 GMT Peñaloza RA, Sarkar U, Claman DM, et al. <span class="paragraphSection">Modafinil is a nonamphetamine stimulant approved for narcolepsy, obstructive sleep apnea, and shift-work sleep disorder. Off-label use is often recommended, but regulatory agencies have raised concerns about hypersensitivity reactions and neuropsychiatric adverse effects. It is unclear how often and for which conditions modafinil is being prescribed in clinical practice.</span> 173 8 704 706 10.1001/jamainternmed.2013.2807 http://archinte.jamanetwork.com/article.aspx?articleID=1669100